Feb 2 (Reuters) - Aeterna Zentaris Inc AEZS.TO :
* AETERNA ZENTARIS ANNOUNCES EVALUATION AND POTENTIAL DEVELOPMENT OF AN ORAL PROPHYLACTIC BACTERIAL VACCINE AGAINST COVID-19 THROUGH EXCLUSIVE OPTION AGREEMENT WITH JULIUS-MAXIMILIANS-UNIVERSITY WUERZBURG
* AETERNA ZENTARIS INC - EVALUATE UNIVERSITY'S CORONAVIRUS VACCINE PLATFORM TECHNOLOGY INCLUDING COVID-19 UNDER AN EXCLUSIVE OPTION AGREEMENT
* AETERNA ZENTARIS - HAS RIGHT TO NEGOTIATE EXCLUSIVE WORLDWIDE LICENSE TO DEVELOP TECHNOLOGY FOR PREVENTION OF CORONAVIRUS DISEASES, INCLUDING COVID-19